4.8 Article

Diagnosis of Esophageal Squamous Cell Carcinoma by High-Performance Serum Metabolic Fingerprints: A Retrospective Study

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases

Yiheng Chen et al.

Summary: Through genome-wide association studies, this study identified associations between 690 metabolites and 248 loci, as well as associations between 143 metabolite ratios and 69 loci. The integration of metabolite-gene and gene expression information revealed 94 effector genes for 109 metabolites and 48 metabolite ratios. The use of Mendelian randomization identified 22 metabolites and 20 metabolite ratios with estimated causal effects on 12 traits and diseases.

NATURE GENETICS (2023)

Article Oncology

H-1 NMR-based metabolomics of paired tissue, serum and urine samples reveals an optimized panel of biofluids metabolic biomarkers for esophageal cancer

Ting Ouyang et al.

Summary: The aim of this study was to improve the non-invasive diagnosis of esophageal squamous cell cancer (ESCC) by establishing an optimized metabolic panel using serum and urine biomarkers. The researchers used the high-resolution 600 MHz 1H-NMR technique to analyze urine and serum specimens from healthy individuals and ESCC patients. They identified distinct metabolites in serum and urine that were linked to the metabolic profiles of esophageal cancer tissues. Creatine and glycine were identified as the optimal biomarkers for ESCC detection. By combining creatine and glycine in serum and urine, a predictive nomogram with superior diagnostic efficiency was constructed. Overall, this study highlights the potential utility of NMR-based metabolomics in the non-invasive detection of ESCC.

FRONTIERS IN ONCOLOGY (2023)

Article Chemistry, Physical

Diagnosis of Unruptured Intracranial Aneurysm by High-Performance Serum Metabolic Fingerprints

Jiabin Su et al.

Summary: Unruptured intracranial aneurysm (UIA) is a high-risk cerebrovascular saccular dilatation. Serum metabolic fingerprints are a promising alternative for early diagnosis. This study applied nanoparticle enhanced laser desorption/ionization mass spectrometry to obtain high-performance UIA-specific serum metabolic fingerprints. The constructed machine learning model achieved a diagnostic performance with an AUC of 0.842 and identified lactate, glutamine, homoarginine, and 3-methylglutaconic acid as the metabolic biomarker panel.

SMALL METHODS (2023)

Article Chemistry, Multidisciplinary

Efficient Metabolic Fingerprinting of Follicular Fluid Encodes Ovarian Reserve and Fertility

Jiao Wu et al.

Summary: Metabolic fingerprinting of follicular fluid (MFFF) using particle-assisted laser desorption/ionization mass spectrometry (PALDI-MS) is performed to encode ovarian reserve (OR) and fertility. Machine learning analysis of MFFF allows for the diagnosis of diminished OR and identification of high-quality oocytes/embryos. Metabolic biomarkers from MFFF also contribute to fertility prediction in clinics.

ADVANCED SCIENCE (2023)

Article Chemistry, Physical

Diagnosis of Parkinson's Disease via the Metabolic Fingerprint in Saliva by Deep Learning

Wei Xu et al.

Summary: Parkinson's disease (PD) is a neurodegenerative disorder that affects over 6 million people worldwide and is expected to double in prevalence due to population aging. Traditional PD diagnosis is time-consuming and low-throughput, lacking body fluid biomarkers. In this study, a noninvasive saliva metabolic fingerprinting (SMF) platform using nanoparticle-enhanced laser desorption-ionization mass spectrometry was developed, achieving excellent diagnostic performance with a deep learning model.

SMALL METHODS (2023)

Article Cell Biology

Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer

Hannah N. Bell et al.

Summary: There is a lack of effective therapies for advanced colorectal cancer (CRC) patients. In the CRC tumor microenvironment, there is an accumulation of metabolic waste products, such as ammonia, due to altered metabolism and proximity to the microbiota. The role of metabolite waste in tumor development, progression, and treatment resistance is not well understood. This study demonstrates that high ammonia levels induce T cell metabolic reprogramming, leading to T cell exhaustion and decreased proliferation. Enhancing ammonia clearance can reactivate T cells and enhance the efficacy of immunotherapies.

CELL METABOLISM (2023)

Article Multidisciplinary Sciences

The transcriptional landscape and diagnostic potential of long non-coding RNAs in esophageal squamous cell carcinoma

Meng Zhou et al.

Summary: This study developed a lncRNA signature predictive of ESCC and validated it across multiple external cohorts. It demonstrated the potential of lncRNAs as non-invasive biomarkers for the early detection of ESCC.

NATURE COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study

Kai Li et al.

Summary: A study focused on tRNA-derived small RNAs in esophageal squamous cell carcinoma (ESCC) has developed a non-invasive biomarker based on salivary exosomes. The study identified specific tsRNA and a previously undocumented small RNA in the salivary exosomes of ESCC patients, tissues, and cells. The bi-signature composed of these small RNAs was able to effectively discriminate ESCC patients from controls and provide prognostic information. Furthermore, the bi-signature can be used to select patients who would benefit from adjuvant therapy.

MOLECULAR CANCER (2022)

Article Biochemistry & Molecular Biology

A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study

Jinsei Miyoshi et al.

Summary: In this study, a circulating microRNA signature for early detection of esophageal squamous cell carcinoma (ESCC) was established and validated in multiple cohorts. The signature showed superior diagnostic performance compared to current clinical serological markers.

MOLECULAR CANCER (2022)

Article Multidisciplinary Sciences

Multi-omic machine learning predictor of breast cancer therapy response

Stephen-John Sammut et al.

Summary: This study demonstrates that the response to breast cancer treatment is influenced by the pre-treatment tumour ecosystem, and a machine learning model incorporating multi-omic features can predict pathological complete response.

NATURE (2022)

Article Oncology

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma

Pan Pan Wang et al.

Summary: Esophageal squamous cell carcinoma (ESCC) is a common and aggressive malignancy, especially in northern China. However, the lack of specific early symptoms and biomarkers often leads to late-stage diagnosis. By studying the metabolic profile, potential biomarkers for early detection and prognosis of ESCC were identified. Additionally, perturbed amino acid and lipid metabolism pathways were found to be important in ESCC. This study provides new insights for early detection and risk stratification of ESCC and has the potential to improve patient outcomes.

FRONTIERS IN ONCOLOGY (2022)

Article Chemistry, Physical

Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting

Wanshan Liu et al.

Summary: The development of an RB monitoring platform using machine learning of aqueous humor metabolic fingerprinting can improve survival rates of RB patients, providing highly sensitive and reproducible monitoring results.

SMALL METHODS (2022)

Article Gastroenterology & Hepatology

Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study

Ruyi Xia et al.

Summary: The study aimed to evaluate the cost-effectiveness of risk-stratified endoscopic screening (RSES) for once in a lifetime esophageal cancer (EC) screening in high-risk areas of China, and identify the optimal risk-score thresholds. The results showed that RSES is cost-effective, with a score threshold of 8 or 9 recommended for screening ages <55 years, and universal endoscopic screening recommended for individuals aged >=55 years.

GASTROINTESTINAL ENDOSCOPY (2022)

Article Multidisciplinary Sciences

Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints

Yida Huang et al.

Summary: High-performance metabolic analysis using fast nanoparticle-enhanced laser desorption/ionization mass spectrometry (NPELDI-MS) was used to record serum metabolic fingerprints (SMFs) of breast cancer patients. The SMFs were used for machine learning to distinguish breast cancer from non-breast cancer, and also for constructing a metabolic prognosis scoring system. Additionally, a panel of differentially enriched metabolites and related pathways in breast cancer serum were identified.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Chemistry, Physical

Glaucoma Characterization by Machine Learning of Tear Metabolic Fingerprinting

Jiao Wu et al.

Summary: Using machine learning of tear metabolic fingerprinting, glaucoma can be diagnosed and monitored noninvasively and quickly. A biomarker panel for glaucoma characterization, including screening, subtyping, and early diagnosis, has been constructed.

SMALL METHODS (2022)

Article Chemistry, Analytical

A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma

Jinhui Zhao et al.

Summary: This study identified potential biomarkers for early screening of esophageal squamous cell carcinoma (ESCC) and characterized the underlying metabolic disturbances using multi-platform metabolomics analysis. A diagnostic panel consisting of five metabolites showed high accuracy in distinguishing ESCC patients from healthy controls.

ANALYTICA CHIMICA ACTA (2022)

Article Chemistry, Multidisciplinary

A One-Stop Shop Decision Tree for Diagnosing and Phenotyping Polycystic Ovarian Syndrome on Serum Metabolic Fingerprints

Ruimin Wang et al.

Summary: This study introduces a nanoparticle-enhanced laser desorption/ionization mass spectrometry platform for one-time serum metabolic fingerprinting in PCOS patients with obesity. A decision tree is constructed to diagnose and phenotype PCOS patients, showing high accuracy and technical robustness.

ADVANCED FUNCTIONAL MATERIALS (2022)

Article Oncology

A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma

Ali H. Zaidi et al.

Summary: Microbial profiles in blood of patients across esophageal adenocarcinoma (EAC) carcinogenesis have unique characteristics, and can be utilized to establish a novel circulating diagnostic and prognostic metagenomic signature for EAC.

BRITISH JOURNAL OF CANCER (2022)

Article Biochemistry & Molecular Biology

Metabolomic profiles predict individual multidisease outcomes

Thore Buergel et al.

Summary: Risk stratification is crucial for early identification and prevention of high-risk individuals and diseases. This study explored the potential of nuclear magnetic resonance (NMR) spectroscopy-derived metabolomic profiles in predicting the risk of 24 common diseases. The results showed that metabolomic profiles were associated with incident rates in all investigated diseases except breast cancer, and the combination of age, sex, and metabolomic profiles outperformed established predictors for 10-year outcome prediction in 15 endpoints. In addition, metabolomic profiles provided predictive information for common diseases even when comprehensive clinical variables were considered. Decision curve analysis demonstrated the clinical utility of predictive improvements at various decision thresholds.

NATURE MEDICINE (2022)

Article Chemistry, Multidisciplinary

Integrative Serum Metabolic Fingerprints Based Multi-Modal Platforms for Lung Adenocarcinoma Early Detection and Pulmonary Nodule Classification

Lin Wang et al.

Summary: A multiplexed assay is developed on a nanoparticle-based laser desorption/ionization mass spectrometry platform for the detection of serum metabolic fingerprints (SMFs) in lung adenocarcinoma (LUAD). A dual modal model, MP-NN, integrating SMFs with protein tumor marker CEA via deep learning, shows superior performance compared to a single modal model. The tri modal model, MPI-RF, integrating SMFs, tumor marker CEA, and image features, demonstrates significantly higher performance in pulmonary nodule classification.

ADVANCED SCIENCE (2022)

Review Nanoscience & Nanotechnology

Portable and visual assays for the detection of SARS-CoV-2

Yufan Zhang et al.

Summary: This article provides an overview of current portable and visual assays for the detection of COVID-19, aiming to achieve early effective and more accurate diagnosis of COVID-19.
Review Nanoscience & Nanotechnology

Using all our genomes: Blood-based liquid biopsies for the early detection of cancer

Eddie Adams et al.

Summary: The pursuit of highly sensitive and specific cancer diagnostics based on cell-free nucleic acids is a research and commercial effort for at least two decades. Using ctDNA for the diagnosis of early-stage cancers remains challenging due to several factors.
Review Nanoscience & Nanotechnology

Biodiagnostics in an era of global pandemics-From biosensing materials to data management

Yoav Y. Broza et al.

Summary: The article discusses the importance of rapid chemical sensing and bio-diagnostic solutions for COVID-19, emphasizing the integration of sensing devices with technologies such as big data analysis to improve the accuracy of disease records. It also provides an outlook on the future requirements and opportunities for enhancing pandemic-related bio-diagnostics.
Article Multidisciplinary Sciences

Multi-omic machine learning predictor of breast cancer therapy response

Stephen-John Sammut et al.

Summary: The response to therapy in breast cancers is influenced by the pre-treated tumour ecosystem, and predictive models integrating multi-omics features through machine learning can be used to predict treatment outcomes. The degree of residual disease following therapy is monotonically associated with pre-therapy features of the tumour.

NATURE (2022)

Article Biochemistry & Molecular Biology

Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma

Jing Cheng et al.

Summary: Integrative transcriptomics and metabolomics analysis indicated that the tyrosine pathway plays a crucial role in the tumorigenesis and metastasis of ESCC by influencing immune response and tumor microenvironment. This study provides insights into the pathogenesis of ESCC and identifies potential biomarkers for disease diagnosis.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Targeted proteomics-derived biomarker profile develops a multi-protein classifier in liquid biopsies for early detection of esophageal squamous cell carcinoma from a population-based case-control study

Xiaorong Yang et al.

Summary: This study demonstrated that a combination of specific serum proteins could serve as a potential tool for screening and early diagnosis of esophageal squamous cell carcinoma, especially with the establishment of a three-level hierarchical screening strategy for disease control.

BIOMARKER RESEARCH (2021)

Article Oncology

Development and Evaluation of Serum CST1 Detection for Early Diagnosis of Esophageal Squamous Cell Carcinoma

Jianwei Wang et al.

Summary: The pilot study showed that CST1 is highly expressed in ESCC tissues, and CLEIA has excellent detection performance for CST1. CST1 may be a prospective serological biomarker for early diagnosis of ESCC, while combination with CEA, SCC-Ag could improve the early diagnostic performance.

CANCER MANAGEMENT AND RESEARCH (2021)

Review Biochemical Research Methods

Ultra-high-performance liquid chromatography high-resolution mass spectrometry variants for metabolomics research

Leonardo Perez de Souza et al.

Summary: This article introduces ultra-high-performance liquid chromatography high-resolution mass spectrometry (UHPLC-HRMS), a highly sensitive and high-throughput technique for analyzing various metabolites. UHPLC provides efficient separation, while HRMS enables high-sensitivity detection, allowing for the detection and identification of a broad range of metabolites. The common strategies for expanding metabolome coverage using UHPLC-HRMS are also discussed.

NATURE METHODS (2021)

Article Medical Laboratory Technology

Development of a panel of autoantibody against NSG1 with CEA, CYFRA21-1, and SCC-Ag for the diagnosis of esophageal squamous cell carcinoma

Qingzhu Zheng et al.

Summary: The expression of NSG1 protein was significantly higher in ESCC tissues than in paracancerous tissues; serum anti-NSG1 levels were significantly higher in the ESCC group compared to the EBL group and HC group; the combination of serum anti-NSG1 with CEA, CYFRA21-1 and SCC-Ag showed the highest diagnostic efficiency for ESCC.

CLINICA CHIMICA ACTA (2021)

Review Nanoscience & Nanotechnology

Applications of digital PCR in COVID-19 pandemic

Chianru Tan et al.

Summary: The COVID-19 pandemic has caused a global public health crisis and panic, with the novel coronavirus SARS-CoV-2 being the cause of this infectious disease. Digital polymerase chain reaction (dPCR) is an emerging nucleic acid amplification technology that allows for the precise quantification of nucleic acids, and is crucial in the detection of SARS-CoV-2 in various applications.
Review Nanoscience & Nanotechnology

Biosensors and sensors for dopamine detection

Xixia Liu et al.

Summary: Dopamine is a critical neurotransmitter in the human central nervous system, and abnormalities in its release are associated with neurological diseases and depression. Current methods for dopamine detection focus on electrochemical detection, fluorescent and colorimetric sensors, with promising advances in combining aptamers or molecularly imprinted polymers to improve detection speed and selectivity.
Review Nanoscience & Nanotechnology

Anisotropic transition metal-based nanomaterials for biomedical applications

Min Xu et al.

Summary: Transition metal-based nanoparticles with unique characteristics and shape effects have attracted attention in biomedicine. Research has focused on developing anisotropic shapes to enhance physicochemical properties and biological activity. Different shape categories of anisotropic transition metal-based nanomaterials offer distinct advantages in biomedical applications.
Article Multidisciplinary Sciences

Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma

Lin Huang et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

A reference map of potential determinants for the human serum metabolome

Noam Bar et al.

NATURE (2020)

Review Oncology

The current state of molecular testing in the treatment of patients with solid tumors, 2019

Wafik S. El-Deiry et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Biochemistry & Molecular Biology

Effects of Long-Term Storage at -80 °C on the Human Plasma Metabolome

Antje Wagner-Golbs et al.

METABOLITES (2019)

Article Biotechnology & Applied Microbiology

Metabolomics activity screening for identifying metabolites that modulate phenotype

Carlos Guijas et al.

NATURE BIOTECHNOLOGY (2018)

Article Genetics & Heredity

The fecal metabolome as a functional readout of the gut microbiome

Jonas Zierer et al.

NATURE GENETICS (2018)

Article Public, Environmental & Occupational Health

Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries

Hongmei Zeng et al.

LANCET GLOBAL HEALTH (2018)

Review Food Science & Technology

Nanoparticle-based laser desorption/ionization mass spectrometric analysis of drugs and metabolites

Han-Wei Chu et al.

JOURNAL OF FOOD AND DRUG ANALYSIS (2018)

Article Biochemistry & Molecular Biology

Long-term stability of oxidative stress biomarkers in human serum

Eugene H. J. M. Jansen et al.

FREE RADICAL RESEARCH (2017)

Review Medicine, General & Internal

Oesophageal cancer

Jesper Lagergren et al.

LANCET (2017)

Article Biochemistry & Molecular Biology

Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma

Wenjian Wang et al.

MOLECULAR CANCER (2017)

Article Pathology

Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma

Ester de Andrade Barreto et al.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)

Article Computer Science, Artificial Intelligence

Discriminative Lasso

Zhihong Zhang et al.

COGNITIVE COMPUTATION (2016)